US consumer and healthcare professional preferences for combination COVID-19 and influenza vaccines
Most US consumers and HCPs would likely prefer a single-shot combination flu + COVID vaccine compared with standalone influenza and COVID-19 vaccines. Given the low COVID-19 vaccination coverage rates in the US, the availability of a combination flu + COVID vaccine could help increase COVID-19 vaccine coverage.
Authors
- Philip O. Buck (ORCID: https://orcid.org/0000-0002-3898-3669)
- Christine Poulos (ORCID: https://orcid.org/0000-0001-7810-3411)
- Parinaz Ghaswalla (ORCID: https://orcid.org/0000-0002-2883-5590)
- Deborah Rudin (ORCID: https://orcid.org/0000-0002-5975-9500)
- Darshan Mehta (ORCID: https://orcid.org/0000-0002-9954-9348)
- Cannon Kent
Institutions
- Moderna Therapeutics (United States) (US)
- RTI Health Solutions (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1080/13696998.2025.2462412
- Citations
- 5
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 10.84
Funders
- Moderna